Miromatrix Medical Inc. financial data

Industry
Biological Products, (No Diagnostic Substances)
Location
6455 Flying Cloud Drive, Suite 107, Eden Prairie, MN
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2023 - Nov 14, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 547 % -51.7%
Debt-to-equity 32.8 % +98.7%
Return On Equity -120 % -84.3%
Return On Assets -90.7 % -61.7%
Operating Margin -2.99K % +96.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 27.4M shares +31.2%
Common Stock, Shares, Outstanding 27.4M shares +31.2%
Entity Public Float 73.5M USD -64.8%
Common Stock, Value, Issued 274 USD +31.1%
Weighted Average Number of Shares Outstanding, Basic 27.3M shares +30.7%
Weighted Average Number of Shares Outstanding, Diluted 27.3M shares +30.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 958K USD +2979%
Research and Development Expense 16.3M USD -2.25%
Operating Income (Loss) -28.6M USD +0.16%
Nonoperating Income (Expense) 181K USD +41.5%
Net Income (Loss) Attributable to Parent -27.4M USD +3.79%
Earnings Per Share, Basic -1.14 USD/shares -65.2%
Earnings Per Share, Diluted -1.14 USD/shares -65.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.12M USD +10.4%
Accounts Receivable, after Allowance for Credit Loss, Current 11.2K USD
Assets, Current 17.2M USD -47.6%
Property, Plant and Equipment, Net 4.71M USD -19%
Operating Lease, Right-of-Use Asset 1.52M USD -11.9%
Assets 23.4M USD -42.3%
Accounts Payable, Current 1.05M USD -9.44%
Accrued Liabilities, Current 2.62M USD +64.8%
Liabilities, Current 4.97M USD +22.4%
Operating Lease, Liability, Noncurrent 2.41M USD -14.7%
Liabilities 7.88M USD +0.18%
Retained Earnings (Accumulated Deficit) -124M USD -28.2%
Stockholders' Equity Attributable to Parent 15.5M USD -52.5%
Liabilities and Equity 23.4M USD -42.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.62M USD -16%
Net Cash Provided by (Used in) Financing Activities 9.04M USD
Net Cash Provided by (Used in) Investing Activities 7.98M USD
Common Stock, Shares Authorized 190M shares 0%
Common Stock, Shares, Issued 27.4M shares +31.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.92M USD +9.12%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3.17K USD -24.8%
Deferred Tax Assets, Valuation Allowance 34.6M USD +163%
Deferred Tax Assets, Gross 34.9M USD +166%
Operating Lease, Liability 2.82M USD -11.9%
Lessee, Operating Lease, Liability, to be Paid 3.18M USD -13.8%
Property, Plant and Equipment, Gross 7.43M USD +0.72%
Operating Lease, Liability, Current 414K USD +8.31%
Lessee, Operating Lease, Liability, to be Paid, Year Two 543K USD +3%
Lessee, Operating Lease, Liability, to be Paid, Year One 527K USD +3%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 361K USD -25.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 559K USD +3%
Deferred Tax Assets, Operating Loss Carryforwards 10.1M USD +45.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 576K USD +3%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 1.16M USD +29.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%